Loading…
Loading grant details…
| Funder | European Commission |
|---|---|
| Recipient Organization | Zygofix Ltd |
| Country | Israel |
| Start Date | Apr 01, 2022 |
| End Date | Mar 31, 2025 |
| Duration | 1,095 days |
| Number of Grantees | 1 |
| Roles | Coordinator |
| Data Source | European Commission |
| Grant ID | 190129138 |
Over 1M spinal fusion procedures performed annually worldwide.
Current spinal fusion procedures are highly invasive: they are based on building screw-bridges, connected by metal rods stabilizing motion between vertebrae.
There are no effective treatments in the market that substitute the current invasive implants. zLOCK is a small implant that resolves spinal fusion by eliminating the need for screws and rods. zLOCK minimizes the invasiveness of procedures through a percutaneous approach, where only a small skin incision is required for implant placement, making it suitable for outpatient procedures. zLOCK can revolutionize spinal fusion standard clinical practice and the market.
The implant value propositions have been confirmed in a first in human trial.
With the EIC Accelerator project, ZygoFix will complete the necessary upgrades and clinical validation activities, achieve CE-mark and accelerate the time-to- market of zLOCK.
Zygofix Ltd
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant